![]() |
|||||||||
| Introduction |
| Early & mid-term results for EVAR Trial 1 |
| Mid-term results for EVAR Trial 2 |
| Current interpretation for EVAR Trial 1 |
| Current interpretation for EVAR Trial 2 |
| Non-expert summary |
| Participating Centres |
| Ethical Approval |
| Outcome Measures |
| Power Calculations |
| Patients |
| Sample group |
| Randomisation |
| Subvention fund |
| Recruitment |
| Follow-up |
| Trial management and data monitoring |
Trial
Summary
> Introduction
>
Methods
> Early & mid-term results for EVAR Trial
1
> Mid-term results for EVAR Trial 2
> Current interpretation for EVAR Trial
1
> Current interpretation for EVAR Trial
2
Methodology
> Participating Centres
> Ethical Approval
> Outcome Measures
> Power Calculations
> Patients
> Sample group
> Randomisation
> Subvention fund
> Recruitment
> Follow-up
> Trial management and data monitoring
Results
> EVAR
Trial 1
> EVAR Trial 2